Have a personal or library account? Click to login
Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical setting Cover

Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical setting

Open Access
|Jan 2012

References

  1. Wahbah M, Boroumand N, Castro C, El-Zeky F, Eltorky M. Changing trends in the distribution of the histologic types of lung cancer: a review of 4,439 cases. Ann Diagn Pathol 2007; 11: 89-96.10.1016/j.anndiagpath.2006.04.006
  2. UICC International Union Against Cancer. Lung. In: Sobin LH, Gospodarowicz MK, Wittekind Ch, editors. TNM classification of malignant tumours. 7th edition. Chichester: Wiley-Blackwell, 2009. p. 138-46.
  3. Debevec L, Jerič T, Kovač V, Sok M, Bitenc M. The progress in routine management of lung cancer patients. A comparative analysis of an institution in 1996 and 2006. Radiol Oncol 2009; 43: 47-53.10.2478/v10019-009-0008-x
  4. Vallières E, Shepherd FA, Crowley J, Van Houtte P, Postmus PE, Carney D, et al; International Association for the Study of Lung Cancer International Staging Committee and Participating Institutions. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2009; 4: 1049-59.10.1097/JTO.0b013e3181b27799
  5. Micke P, Faldum A, Metz T, Beeha K, Bittingerc F, Hengstlerd J, et al. Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer - what limits limited disease? Lung Cancer 2002; 37: 271-6.10.1016/S0169-5002(02)00072-7
  6. Murray N, Turrisi AT 3rd. A review of first-line treatment for small cell lung cancer. J Thorac Oncol 2006; 1: 270-8.10.1016/S1556-0864(15)31579-3
  7. Lee CB, Morris DE, Fried DB, Socinski MA. Current and evolving treatment options for limited stage small cell lung cancer. Curr Opin Oncol 2006; 18: 162-72.10.1097/01.cco.0000208790.45312.2516462186
  8. Strojan P. Role of radiotherapy in melanoma management. Radiol Oncol 2010; 44: 1-12.10.2478/v10019-010-0008-x342366822933884
  9. Park HS, Chiang VL, Knisely JP, Raldow AC, Yu JB. Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: an update. Expert Rev Anticancer Ther 2011; 11: 1731-8.10.1586/era.11.16522050022
  10. Tran TA, Wu V, Malhotra H, Steinman JP, Prasad D, Podgorsak MB. Target and peripheral dose from radiation sector motions accompanying couch repositioning of patient coordinates with the Gamma Knife® Perfexion™. Radiol Oncol 2011; 45: 132-142.10.2478/v10019-011-0012-9342372522933947
  11. Giannone L, Johnson DH, Hande KR, Greco FA. Favorable prognosis of brain metastases in small cell lung cancer. Ann Intern Med 1987; 106: 386-9.10.7326/0003-4819-106-3-3863028222
  12. van Hazel GA, Scott M, Eagan RT. The effect of CNS metastases on the survival of patients with small cell cancer of the lung. Cancer 1983; 51: 933-7.10.1002/1097-0142(19830301)51:5<;933::AID-CNCR2820510528>3.0.CO;2-Q
  13. van Oosterhout AG, van de Pol M, ten Velde GP, Twijnstra A. Neurologic disorder in 203 consecutive patients with small cell lung cancer. Cancer 1996; 77: 1434-41.10.1002/(SICI)1097-0142(19960415)77:8<;1434::AID-CNCR3>3.0.CO;2-C
  14. Pozek I, Rozman A. Lung cancer seeding along needle track after CT guided transthoracic fine-needle aspiration biopsy - case report. Zdrav Vestn 2010; 79: 659-62.
  15. Crane JM, Nelson MJ, Ihde DC, Makuch RW, Glatstein E, Zabell A, et al. A comparison of computed tomography and radionuclide scanning for detection of brain metastases in small cell lung cancer. J Clin Oncol 1984; 2: 1017-24.10.1200/JCO.1984.2.9.1017
  16. Arinc S, Gonlugur U, Devran O, Erdal N, Ece F, Ertugrul M, et al. Prognostic factors in patients with small cell lung carcinoma. Med Oncol 2010; 27: 237-41.10.1007/s12032-009-9198-8
  17. Ihde DC, Makuch RW, Carney DN, Bunn PA, Cohen MH, Matthews MJ, et al. Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy. Am Rev Respir Dis 1981; 123: 500-7.
  18. Bremnes RM, Sundstrom S, Aasebø U, Kaasa S, Hatlevoll R, Aamdal S; Norweigian Lung Cancer Study Group. The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up. Lung Cancer 2003; 39: 303-13.10.1016/S0169-5002(02)00508-1
  19. Stanic K, Kovac V. Prophylactic cranial irradiation in patients with small-cell lung cancer: the experience at the Institute of Oncology Ljubljana. Radiol Oncol 2010, 44: 180-6.10.2478/v10019-010-0038-4
  20. Kochhar R, Frytak S, Shaw EG. Survival of patients with extensive small-cell lung cancer who have only brain metastases at initial diagnosis. Am J Clin Oncol 1997; 20: 125-7.10.1097/00000421-199704000-00003
  21. Rankin E, Snee M, Hatton M, Postmus P, Collette L, Musat E; EORTC Radiation Oncology Group and Lung Cancer Group. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007; 357: 664-72.10.1056/NEJMoa071780
  22. Lee JJ, Bekele BN, Zhou X, Cantor SB, Komaki R, Lee JS. Decision analysis for prophylactic cranial irradiation for patients with small sell lung cancer. J Clin Oncol 2006; 24: 3597-603.10.1200/JCO.2006.06.0632
  23. Blanchard P, Le Pechoux C. Prophylactic cranial irradiation in lung cancer. Curr Opin Oncol 2010; 22: 94-101.10.1097/CCO.0b013e32833500ef
  24. Aupérin A, Arriagada R, Pignon JP, Le Péchoux C, Gregor A, Stephens RJ, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999; 341: 476-8.10.1056/NEJM199908123410703
  25. Le Pechoux C, Dunant A, Senan S, Wolfson A, Quoix E, Faivre-Finn C, et al. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial. Lancet Oncol 2009; 10: 467-74.10.1016/S1470-2045(09)70101-9
  26. Meert AP, Paesmans M, Berghmans T, Martin B, Mascaux C, Vallot F, et al. Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer 2001; 1: 5.10.1186/1471-2407-1-53409611432756
  27. Paumier A, Cuenca X, Le Péchoux C. Prophylactic cranial irradiation in lung cancer. Cancer Treat Rev 2011; 37: 261-5.10.1016/j.ctrv.2010.08.00920934256
  28. Tiseo M, Ardizzoni A. Current status of second-line treatment and novel therapies for small cell lung cancer. J Thorac Oncol 2007; 2: 764-72.10.1097/JTO.0b013e318098626217762346
  29. Kalemkerian GP. Advances in the treatment of small-cell lung cancer. Semin Respir Crit Care Med 2011; 32: 94-101.10.1055/s-0031-127287321500128
  30. Metro G, Cappuzzo F. Emerging drugs for small-cell lung cancer. Expert Opin Emerg Drugs 2009; 14: 591-606.10.1517/1472821090320698319694501
DOI: https://doi.org/10.2478/v10019-012-0007-1 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 54 - 59
Published on: Jan 2, 2012
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2012 Mirko Lekic, Viljem Kovac, Nadja Triller, Lea Knez, Aleksander Sadikov, Tanja Cufer, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 46 (2012): Issue 1 (March 2012)